European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. . VPAS tax on top. .

Pharma 70

Pharma Government Manufacturing Competition 70

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. In the near term, manufacturers may need to reconsider price increase strategy given inflation penalties for Medicare beneficiaries.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. biologics market and reduce prescription drug costs. In 2022, it made its manufacturer, AbbVie, $21.2bn. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

Medicine 94

Medicine Healthcare Healthcare Pharma 94

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. exclusions exist for orphan drug designation and biosimilar competition ). With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

PM360

APRIL 7, 2023

In addition to the revenue they drive through contracts on branded products, they generate profit through administration fees for all claims they process and the direct sale of drugs—both branded and generic—through their own mail-order pharmacies.

Marketing 52

Marketing Prescription Insurance Retail 52

pharmaphorum

JULY 15, 2022

A district court judge later overturned the first verdict, but a US appeals court in 2020 reinstated the $235 million judgment against the generics manufacturer. GSK claimed patent infringement, but Teva argued that the ‘000 patent should not apply as it was granted after it launched its generic.

Prescription 52

Prescription Doctors Government Marketing 52

Evolve Your Success

MARCH 12, 2024

When Brooke Elliott got the chance to mentor medical sales reps to become the industry’s next-generation leaders, she found fulfillment in becoming a full-time coach. In this special episode for Women’s History Month and International Women’s Day, Brooke joins Samuel Adeyinka to share how she brings out the best in medical sales reps today.

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

Evolve Your Success

OCTOBER 17, 2023

Pharmaceutical sales isn’t just about selling pills; it’s about crafting a winning plan, staying coachable, and asking for help when you need it. Zach dives into the fast-paced and competitive nature of pharmaceutical sales, where success is about more than just having a prescription pad. I am fantastic.

Pharmaceutical Sales 64

Pharmaceutical Sales Sales Pharmaceutical Medical sales 64

pharmaphorum

JANUARY 9, 2023

Deglobalisation has, however, not gone away and 2023 will see acceleration of this trend, manifested in the following: Lower- and middle-income countries (LMICs) were exposed to medicine supply issues because of the pandemic, as they lacked both funds to secure supply and their own manufacturing capacity. Pharma boxed in?

Medicine 91

Medicine Healthcare Healthcare Pharma 91

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. With major IRA provisions going into effect over the next few years, it is critical for drug manufacturers to understand and prepare for the implications to their business.

Government 97

Government Manufacturing Prescription Competition 97

Pharmaceutical Technology

JULY 23, 2008

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler. So what’s driving the growth?

Side effects 52

Side effects Marketing Pharmaceutical Sales 52

Pharmaceutical Technology

MAY 26, 2023

The FDA has flagged this issue as pharmacies selling prescription drugs illegally have proliferated over the years. The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Throughout 2022, Novartis was at the opposing ends of legal cases.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

World of DTC Marketing

JUNE 16, 2021

This includes about one in five who report that they have not filled a prescription or took an over-the counter drug instead, and about one in ten who say they have cut pills in half or skipped a dose. The public sees profits made by pharmaceutical companies as the largest factor contributing to the price of prescription drugs.

Prescription 180

Prescription Government Insurance Pharma 180

World of DTC Marketing

DECEMBER 14, 2021

According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. That’s because there are a limited number of manufactures in the U.S.Several states have put caps on insulin co-pays that range from $25 to $100 for a monthly supply.

Prescription 184

Prescription Pharma Marketing Competition 184